[1] 莫承强,刘畅,陈旭, 等.尿液中ErbB3蛋白在肾透明细胞癌早期诊断中的意义[J].中山大学学报(医学科学版),2018,32(2):269-273.
[2] 韩希年,彭令荣,刘光华, 等.肾透明细胞癌的CT、MRI诊断[J].中国医学影像技术,2005,28(5):776-778.
[3] 张磊,王震寰,袁玉山, 等.多层螺旋CT多期扫描对透明细胞肾癌的诊断价值[J].蚌埠医学院学报,2016,(5):649-651.
[4] 吴娟,顾红梅,王欣全, 等.肾透明细胞癌、嫌色细胞癌及嗜酸细胞腺瘤的MSCT鉴别诊断[J].中国医学计算机成像杂志,2017,35(1):46-52.
[5] Puerta-Gil P,Garca-Baquero R,Jia AY,et al.MiR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer[J].Am J Pathol,2012,180(5):1808-1815.
[6] Kumar A,Coleman I,Morrissey C,et al.Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer[J].Nat Med,2016, 22(4): 369-378.
[7] Nishii T,Yokose T,Miyagi Y,et al.Prognostic value of EGFR mutations in surgically resected pathological stage I lung adenocarcinoma[J].Asia Pac J Clin Oncol,2017, 13(5):e204-211.
[8] 刘常青,邢伟,孙军, 等.MRI增强检查对肾透明细胞癌与乳头状细胞癌的鉴别诊断价值[J].中国临床医学影像杂志,2014,(6):426-428,432. |
2019, Vol. 36 
